Hyperkalemia in the Cardiometabolic Patient: What Are the Stages of Treatment? How Should We Approach HF Patients? Should We Worry About Mild Hyperkalemia?

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Hyperkalemia in the Cardiometabolic Patient: What Are the Stages of Treatment? How Should We Approach HF Patients? Should We Worry About Mild Hyperkalemia?

By Cardiometabolic Health Congress (CMHC) FEATURING Javed Butler

94 views

January 28, 2021

0 Comments

HRS 2024: CCM® Therapy for Symptomatic Heart Failure: When CRT Isn…

Feat. R. Kahwash, L. Chinitz, N. Varma, S. Jamal, J. Singh

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Cardiovascular Summit at Kiawah 2024

Thu, Jul 18, 2024

11:37

ACC 2022 Conference Coverage

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

Feat. P. Heidenreich

11:25

ACC 2023 Conference Coverage

ACC 2023: SGLT2i Use - Dos and Don'ts

Feat. A. Armbruster

27:14

MUSC Cardiology

Which Diuretic(s) Are Best in HF? Update Based on Recent Clinical Tr…

Feat. R. Mentz

17:44

Rita Jermyn

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

13:01

CCM® Therapy

EHRA 2024: Ongoing Clinical Investigations with Cardiac Contractil…

Feat. N. Varma

19:53

CCM® Therapy

EHRA 2024: Cardiac Contractility Modulation: Innovative Therapy f…

Feat. V. Reddy, N. Varma, K. Kuck, J. Kuschyk, N. Aspromonte

14:58

CCM® Therapy

EHRA 2024: Real-World Experience with Cardiac Contractility Modulat…

Feat. J. Kuschyk

13:07

Michelle Kittleson

2021 ADA Highlights: Heart Failure With Reduced Ejection Fraction - …

09:52

AHA 2022 Conference Coverage

AHA 2022: Torsemide Comparison With Furosemide for Management of Hea…

Feat. R. Mentz

63:15

Getinge

SCAI SHOCK 2023: Strategies to Disrupt SCAI Stage B Progression

Feat. J. O'Grady, J. Katz, N. Kapur, A. Dupont, R. Kataria

55:57

CCM® Therapy

EHRA 2024: Cardiac Contractility Modulation: Innovation Therapy fo…

Feat. K. Kuck, J. Kuschyk, V. Reddy, N. Aspromonte, N. Varma

18:34

Houston Methodist DeBakey Heart and Vascular Center

ECG Interpretation: Everything You Need to Know to Understand and In…

Feat. A. Dave

13:17

Getinge

HFSA 2023 - Physiological and Clinical Effects of Counterpulsation i…

Feat. I. Isseh

15:38

CCM® Therapy

THT 2024: CCM® Therapy - Don’t Wait!

Feat. R. Kahwash

14:49

Getinge

HFSA 2023 - Navigating MCS Selection Amidst the RCT Evidence Gap.

Feat. D. Baran

29:08

Scripps Health

Case Presentation: Complex PCI with IABP

Feat. R. Khedraki, T. Heywood, R. Mohan, A. Srivastava

08:06

CCM® Therapy

EHRA 2024: Unmet Medical Needs in Heart Failure Management: Can D…

Feat. N. Aspromonte

15:47

Scripps Health

HFpEF in Women

Feat. B. Borlaug

35:16

Scripps Health

HFpEF or Amyloidosis? The Right Therapies for Right Patients

Feat. M. Kittleson

10:38

Getinge

HFSA 2023 - Counterpulsation Applications in Heart Failure: Restrict…

Feat. R. Lee

Login

Login

Join VuMedi

Hyperkalemia in the Cardiometabolic Patient: What Are the Stages of Treatment? How Should We Approach HF Patients? Should We Worry About Mild Hyperkalemia?

Related Content